120 related articles for article (PubMed ID: 9672379)
1. Longitudinal study of cerebrospinal fluid amyloid proteins and apolipoprotein E in patients with probable Alzheimer's disease.
Pirttilä T; Koivisto K; Mehta PD; Reinikainen K; Kim KS; Kilkku O; Heinonen E; Soininen H; Riekkinen P; Wisniewski HM
Neurosci Lett; 1998 Jun; 249(1):21-4. PubMed ID: 9672379
[TBL] [Abstract][Full Text] [Related]
2. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
3. High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia.
Vijayaraghavan S; Maetzler W; Reimold M; Lithner CU; Liepelt-Scarfone I; Berg D; Darreh-Shori T
Alzheimers Dement; 2014 Sep; 10(5):530-540.e1. PubMed ID: 23978325
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
5. Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients.
Olsson A; Höglund K; Sjögren M; Andreasen N; Minthon L; Lannfelt L; Buerger K; Möller HJ; Hampel H; Davidsson P; Blennow K
Exp Neurol; 2003 Sep; 183(1):74-80. PubMed ID: 12957490
[TBL] [Abstract][Full Text] [Related]
6. Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.
Zimetti F; Caffarra P; Ronda N; Favari E; Adorni MP; Zanotti I; Bernini F; Barocco F; Spallazzi M; Galimberti D; Ricci C; Ruscica M; Corsini A; Ferri N
J Alzheimers Dis; 2017; 55(1):315-320. PubMed ID: 27662294
[TBL] [Abstract][Full Text] [Related]
7. Association of CSF apolipoprotein E, Abeta42 and cognition in Alzheimer's disease.
Riemenschneider M; Schmolke M; Lautenschlager N; Vanderstichele H; Vanmechelen E; Guder WG; Kurz A
Neurobiol Aging; 2002; 23(2):205-11. PubMed ID: 11804704
[TBL] [Abstract][Full Text] [Related]
8. CSF beta-amyloid, cognition, and APOE genotype in Alzheimer's disease.
Samuels SC; Silverman JM; Marin DB; Peskind ER; Younki SG; Greenberg DA; Schnur E; Santoro J; Davis KL
Neurology; 1999 Feb; 52(3):547-51. PubMed ID: 10025785
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity.
Hock C; Golombowski S; Müller-Spahn F; Naser W; Beyreuther K; Mönning U; Schenk D; Vigo-Pelfrey C; Bush AM; Moir R; Tanzi RE; Growdon JH; Nitsch RM
Eur Neurol; 1998; 39(2):111-8. PubMed ID: 9520072
[TBL] [Abstract][Full Text] [Related]
10. Baseline CSF/Serum-Ratio of Apolipoprotein E and Rate of Differential Decline in Alzheimer's Disease.
Schmidt C; Gerlach N; Schmitz M; Thom T; Kramer K; Friede T; Zerr I
J Alzheimers Dis; 2015; 48(1):189-96. PubMed ID: 26401939
[TBL] [Abstract][Full Text] [Related]
11. Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid.
Ma QL; Galasko DR; Ringman JM; Vinters HV; Edland SD; Pomakian J; Ubeda OJ; Rosario ER; Teter B; Frautschy SA; Cole GM
Arch Neurol; 2009 Apr; 66(4):448-57. PubMed ID: 19364929
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E4 accelerates dementia and increases cerebrospinal fluid tau levels in Alzheimer's disease.
Kanai M; Shizuka M; Urakami K; Matsubara E; Harigaya Y; Okamoto K; Shoji M
Neurosci Lett; 1999 May; 267(1):65-8. PubMed ID: 10400250
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal beta-amyloid ((1-42)) in early Alzheimer's disease: association with apolipoprotein E genotype and cognitive decline.
Riemenschneider M; Schmolke M; Lautenschlager N; Guder WG; Vanderstichele H; Vanmechelen E; Kurz A
Neurosci Lett; 2000 Apr; 284(1-2):85-8. PubMed ID: 10771168
[TBL] [Abstract][Full Text] [Related]
14. Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease.
Bekris LM; Galloway NM; Millard S; Lockhart D; Li G; Galasko DR; Farlow MR; Clark CM; Quinn JF; Kaye JA; Schellenberg GD; Leverenz JB; Seubert P; Tsuang DW; Peskind ER; Yu CE
Neurobiol Aging; 2011 Mar; 32(3):556.e13-23. PubMed ID: 21196064
[TBL] [Abstract][Full Text] [Related]
15. Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases.
Minta K; Brinkmalm G; Janelidze S; Sjödin S; Portelius E; Stomrud E; Zetterberg H; Blennow K; Hansson O; Andreasson U
Alzheimers Res Ther; 2020 Feb; 12(1):19. PubMed ID: 32054532
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid concentrations of soluble amyloid beta-protein and apolipoprotein E in patients with Alzheimer's disease: correlations with amyloid load in the brain.
Pirttilä T; Mehta PD; Soininen H; Kim KS; Heinonen O; Paljärvi L; Kosunen O; Riekkinen P; Wisniewski HM
Arch Neurol; 1996 Feb; 53(2):189-93. PubMed ID: 8639071
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
18. Stability of CSF beta-amyloid(1-42) and tau levels by APOE genotype in Alzheimer patients.
Huey ED; Mirza N; Putnam KT; Soares H; Csako G; Levy JA; Copenhaver B; Cohen RM; Sunderland T
Dement Geriatr Cogn Disord; 2006; 22(1):48-53. PubMed ID: 16682793
[TBL] [Abstract][Full Text] [Related]
19. Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid.
Falahati F; Ferreira D; Muehlboeck JS; Eriksdotter M; Simmons A; Wahlund LO; Westman E
Neuroimage Clin; 2017; 16():418-428. PubMed ID: 28879083
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype.
Nitsch RM; Rebeck GW; Deng M; Richardson UI; Tennis M; Schenk DB; Vigo-Pelfrey C; Lieberburg I; Wurtman RJ; Hyman BT
Ann Neurol; 1995 Apr; 37(4):512-8. PubMed ID: 7717688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
